This educational programme focuses on putative mechanistic links between epilepsy and cardiovascular disease, raises clinically relevant questions about anti-epileptic drug use in the context of cardiac disease, and addresses unresolved issues of practical importance in this area of “neuro-cardiology”.
Sudden unexpected death in epilepsy (SUDEP): What is the cause?
02/15/2016 - Sudden death in athletes - Professor Sanjay Sharma, St George's, University of London, UK
01/25/2016 - Prevention of Sudden Cardiac Death - Dr Elijah Behr, Cardiac Research Centre, St George's University of London, UK
12/28/2015 - Sudden Cardiac Death Syndrome in South Asians living in the UK - Dr Rajay Narain, Clinical and Research Cardiologist, St George’s University of London, UK
09/02/2015 - Long QT syndrome and epilepsy -
06/26/2015 - Management of angina and the role of Ranolazine in the context of the NICE guidelines -
06/26/2015 - Clinical cases where an indication for ranolazine may exist - Dr Rajan Sharma, St Geroge's University of London
06/26/2015 - Antianginal agents: Beneficial effects of Ranolazine -